Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai LO,Hirunras K, Kitayaporn D, Kaewkangwal J, Migasena S, Sheppard HW, Li E, Chernow M, Peterson ML, Shibata R, Heyward WL, Francis DP. Phase I/II Study of a candidate vaccine designed against the B and E subtypes of  HIV-1. J Acquir Immune Defic Syndr 2004;37:1160-5.

Paris R, Bejrachandra S, Karnasuta C, Chandanayingyong D, Kunachiwa W, Leetrakool N, Prakalapakorn S, Thongcharoen P, Nittayaphan S, Pitisuttithum P, Suriyanon V, Guruthan S, McNeil JG. Brown AE, Birx DL, de Souza M. HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp 120 or oligomeric gp 160 protein boosting. Tissue Antigens 2004;64:251-6.

Nitayaphan S, Pitisuttithum P, Karnasuta C, Eamsila C, de Souza M, Morgan P, Polonis V, Benenson M, VanCott T, Ratto-Kim S, Kim J, Thapinta D, Garnern R, Bussaratid V, Singharaj P, el-Habib R, Gurunathan S, Heyward W, Birx D, McNeil J, Brown AE; Thai AIDS Vaccine Evaluation Group. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis 2004; 190:702-6.

Vanichseni S, Tappero JW, Pitisuttithum P, Kitayaporn D, Mastro TD, Vimutisunthorn E, Van Griensven F, Heyward WL, Francis DP, Choopanya K, for the Bangkok Vaccine Evaluation Group. Recruitment, screening and characteristics of infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS  2004; 18:311-316.

Van Griensven F, KeawKungwal J, Tappero JW, Sangkum U, Pitisuttithum P, Vanichseni S,

Suntharasamai P, Orelind K, Gee C, Choopanya K for the Bangkok Vaccine Evaluation Group. Lack of increased HIV risk behavior among infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS  2004; 18:295-301

Home